News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,676 Results
Type
Article (8207)
Company Profile (140)
Press Release (477328)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (167051)
Career Advice (310)
Deals (25788)
Drug Delivery (7)
Drug Development (52899)
Employer Resources (17)
FDA (9769)
Job Trends (8606)
News (238525)
Policy (17944)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (496)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33247)
ALS (105)
Alzheimer's disease (977)
Antibody-drug conjugate (ADC) (264)
Approvals (10392)
Artificial intelligence (326)
ASCO (159)
Autoimmune disease (207)
Automation (28)
Bankruptcy (262)
Best Places to Work (6982)
BIO (36)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (511)
Cancer (3667)
Cardiovascular disease (218)
Career advice (252)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47908)
Collaboration (1250)
Commercialization (3)
Compensation (1472)
Complete response letters (34)
COVID-19 (763)
CRISPR (63)
C-suite (756)
Cystic fibrosis (85)
Data (5681)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (344)
Diagnostics (4232)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (159)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73746)
Editorial (2)
Employer branding (4)
Employer resources (17)
Events (87731)
Executive appointments (706)
FDA (12417)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (927)
Gene editing (125)
Generative AI (9)
Gene therapy (319)
GLP-1 (294)
Government (962)
Grass and pollen (2)
Guidances (281)
Healthcare (9351)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (951)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (256)
Interviews (42)
IPO (12406)
IRA (2)
Job creations (1982)
Job search strategy (241)
JPM (3)
Kidney cancer (16)
Layoffs (64)
Legal (5226)
Licensing (10)
Liver cancer (44)
Longevity (17)
Lung cancer (510)
Lymphoma (252)
Machine learning (27)
Management (3)
Manufacturing (538)
Marketing (8)
MASH (120)
Medical device (8665)
Medtech (8811)
Mergers & acquisitions (14420)
Metabolic disorders (711)
mRNA (59)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1829)
NextGen: Class of 2026 (3175)
Non-profit (852)
Obesity (226)
Opinion (13)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (198)
Parkinson's disease (201)
Partnered (12)
Patents (477)
Patient recruitment (511)
Peanut (31)
People (41376)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15478)
Phase 2 (21394)
Phase 3 (14420)
Pipeline (7389)
Policy (19)
Postmarket research (1572)
Preclinical (6544)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (580)
Real estate (3040)
Recruiting (8)
Regulatory (14879)
Reports (21)
Research institute (595)
Resumes & cover letters (47)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (157)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2045)
Stomach cancer (3)
Supply chain (50)
Vaccines (326)
Venture capital (18)
Weight loss (73)
Women's health (81)
Date
Today (45)
Last 7 days (224)
Last 30 days (1642)
Last 365 days (19046)
2026 (12448)
2025 (19273)
2024 (23028)
2023 (26604)
2022 (34670)
2021 (37251)
2020 (33545)
2019 (23331)
2018 (17541)
2017 (18860)
2016 (17994)
2015 (24311)
2014 (21706)
2013 (18152)
2012 (20243)
2011 (20471)
2010 (20352)
Location
Africa (232)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17973)
Australia (2105)
California (12027)
Canada (3157)
China (528)
Colorado (485)
Connecticut (412)
Delaware (208)
Europe (24814)
Florida (1799)
Georgia (385)
Hawaii (3)
Idaho (46)
Illinois (703)
India (52)
Indiana (315)
Iowa (15)
Japan (406)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1208)
Massachusetts (7876)
Michigan (308)
Minnesota (563)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2627)
New Mexico (12)
New York (2827)
North Carolina (1286)
North Dakota (4)
Northern California (6032)
Ohio (280)
Oklahoma (14)
Oregon (16)
Pennsylvania (2258)
Puerto Rico (20)
Rhode Island (30)
South America (410)
South Carolina (76)
South Dakota (1)
Southern California (4992)
Tennessee (120)
Texas (1946)
United States (39019)
Utah (362)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (932)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,676 Results for "illumina inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
July 28, 2026
·
12 min read
Press Releases
Bifrost Biosystems Pens Agreement with Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform
July 8, 2026
·
2 min read
Press Releases
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
June 2, 2026
·
5 min read
Press Releases
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
February 26, 2026
·
3 min read
Press Releases
Standard BioTools Completes Sale of SomaLogic to Illumina
February 1, 2026
·
6 min read
Press Releases
Illumina and PREMIA partner to expand clinical access to CGP in Asia
January 8, 2026
·
2 min read
Press Releases
Greenstone Biosciences and Illumina announce collaboration to advance precision drug discovery
October 24, 2025
·
1 min read
Biotech Beach
Illumina To Webcast Upcoming May 2024 Investor Conference
Illumina, Inc. announced that its executives will be speaking at the following investor conference.
May 15, 2024
·
1 min read
Policy
EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail
After a years-long antitrust battle, the European Commission on Friday approved Illumina’s plans to divest Grail. However, Illumina said while there is “an agreement with the EC on specific divestment options” that “does not mean the method of divestment has been finalized.”
April 12, 2024
·
2 min read
·
Tyler Patchen
Biotech Beach
Illumina releases 2023 Corporate Social Responsibility Report
Illumina Inc., a global leader in DNA sequencing and array-based technologies, published its fifth annual Corporate Social Responsibility Report.
May 28, 2024
·
4 min read
1 of 48,568
Next
